🇺🇸 FDA
Pipeline program

CG0070 Adenovirus Vector

12154

Phase 3 mab terminated

Quick answer

CG0070 Adenovirus Vector for Transitional Cell Carcinoma is a Phase 3 program (mab) at CG Oncology with 1 ClinicalTrials.gov record(s).

Program details

Company
CG Oncology
Indication
Transitional Cell Carcinoma
Phase
Phase 3
Modality
mab
Status
terminated

Clinical trials